Plain-English translation of NCT06935591 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a new artificial intelligence system called vMap® can help doctors better treat atrial fibrillation (an irregular heartbeat) by improving how they perform ablation procedures. Ablation is a treatment that uses heat or cold to create scar tissue in the heart to restore normal rhythm. Half of participants will receive the standard ablation procedure alone, while the other half will receive the same procedure enhanced by the vMap® system, which uses computer mapping to identify additional areas of the heart that may be driving the irregular rhythm.
Standard ablation for persistent atrial fibrillation focuses on isolating the pulmonary veins, but some patients continue to have irregular heartbeats even after this procedure. This trial is exploring whether this new mapping technology can identify and treat other areas of the heart that contribute to the arrhythmia, potentially improving long-term success rates.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either standard ablation alone or standard ablation combined with the new vMap® mapping system. Both groups will undergo an ablation procedure following normal clinical practices. The study will compare how well each approach works in controlling your atrial fibrillation over time. Your medical records and heart rhythm data will be reviewed, and you will need to comply with study follow-up visits and monitoring as instructed by your doctor.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States